AMBALALSA.NSE

Ambalal Sarabhai Enterprises Ltd.

Co-Diagnostics Inc. (NASDAQ: CODX ) on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd , to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal, and Sri Lanka. CoSara is the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises Limited. Co-Diagnostics, most recently, regained NASDAQ listing compliance . Territory Expansion Unlocks $13 Billion Market Opportunity The expansion significantly increases CoSara's addressable market across South Asia, bringing the total regional opportunity to an estimated $13 billion based on internal analyses and third-party market data. It also supports CoSara's plans to commercialize the CoSara PCR Pro point-of-care instrument and tests, as well as the SARAGENE product line across the region, subject to applicable regulatory approvals. As part of this expansion, CoSara is working to establish distribution channels in these ... Full story available on Benzinga.com